What the first approved myostatin-blocking drug does, what it doesn’t, and how to protect muscle with food and lifting today.
Videos are calling it a muscle-growth drug, and it did just get FDA approval. The approval covers far less than the headlines suggest.
What was approved, and for whom
The FDA approved apitegromab (brand name Isembyld) in September 2026 to treat spinal muscular atrophy in adults and children 2 and older, a rare genetic disease, alongside existing therapies. It’s not cleared for bodybuilding or for weight loss. It blocks myostatin, a protein that limits muscle growth. People born with a myostatin mutation can have unusually large muscles, which is why lifters find the idea exciting.
It’s given by IV infusion every 4 weeks, and the list price is about $310,000 a year for a typical patient. In the approval trial, fractures occurred in 9% of treated patients versus 2% on placebo.
The weight-loss trial behind the hype
The buzz for lifters comes from a separate phase 2 trial, EMBRAZE, which gave 100 adults with overweight or obesity tirzepatide plus either apitegromab or placebo for 24 weeks.
- Lean mass lost: 3.5 lb with the drug versus 7.7 lb with placebo.
- Fat lost: 18.8 lb versus 17.7 lb.
- Total weight lost: 12.3% versus 13.4%.
The company reported those results. Outside scientists point out that the trial was small, long-term effects are unknown, and it’s unclear whether the preserved lean mass matters clinically. Strength gains were minor.
Key takeaway: This is a rare-disease drug with a promising side result, not a muscle-building shortcut.
What works today
Weight-loss drugs do cost muscle: about 30.8% of the weight lost in one meta-analysis. For anyone dieting, the proven tools are lifting and enough protein. A meta-analysis of 49 studies found that gains from extra protein leveled off at about 0.73 g per pound a day for people who train. We cover the details in our daily protein plan.
Hitting that number is mostly a habit problem, and that’s what Proteinly is for. It takes a protein-first approach without calorie counting, plus an automatic eating timer that reminds you to eat every 2 hours so protein doesn’t get squeezed into one late meal.
Frequently asked questions
Can I get a myostatin inhibitor for muscle gain?
No. The only approved use is spinal muscular atrophy, and it requires a prescription and infusions at a clinic.
Is it safe to buy “myostatin” products online?
Unapproved products have none of the trial data above. Talk to a doctor before taking any prescription drug or peptide.
Will more drugs like this arrive?
Possibly. The EMBRAZE results are early, and nothing yet shows a benefit for healthy lifters.
Next steps
Keep lifting, hit your protein target, and let the research mature. For more, visit Proteinly, browse our articles, or find us on YouTube.
Idea from Renaissance Periodization’s video “The First FDA Approved Muscle Growth Drug Is Here! Here’s the Catch.”